Pharmacogenomics Corner

Back to articles

Many people have CYP gene variations associated with severe drug interactions


A retrospective analysis of more than 22,000 patients who underwent pharmacogenetic testing for polymorphisms of five cytochrome (CYP) isoenzymes showed that the majority of patients had multiple risk-associated phenotypes, which may result in severe interactions.


Hocum BT, et al. Cytochrome P-450 gene and drug interaction analysis in patients referred for pharmacogenetic testing. Am J Health-Syst Pharm. 2016;73(2):61–7.